Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FLGC
Upturn stock ratingUpturn stock rating

Flora Growth Corp (FLGC)

Upturn stock ratingUpturn stock rating
$0.84
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/11/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -95.36%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/11/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 16.20M USD
Price to earnings Ratio -
1Y Target Price 4
Price to earnings Ratio -
1Y Target Price 4
Volume (30-day avg) 254475
Beta 2
52 Weeks Range 0.72 - 2.93
Updated Date 02/21/2025
52 Weeks Range 0.72 - 2.93
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.35

Revenue by Products

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -30.99%
Operating Margin (TTM) -26.31%

Management Effectiveness

Return on Assets (TTM) -22.3%
Return on Equity (TTM) -185.18%

Valuation

Trailing PE -
Forward PE 13.42
Enterprise Value 18190503
Price to Sales(TTM) 0.25
Enterprise Value 18190503
Price to Sales(TTM) 0.25
Enterprise Value to Revenue 0.28
Enterprise Value to EBITDA -1
Shares Outstanding 18200600
Shares Floating 10295306
Shares Outstanding 18200600
Shares Floating 10295306
Percent Insiders 35.25
Percent Institutions 8.36

AI Summary

Flora Growth Corp.: A Comprehensive Overview

Company Profile:

History & Background: Flora Growth Corp. (NASDAQ: FLGC) is a multi-state, vertically integrated cannabis company headquartered in Toronto, Canada, with operations in Colombia, the United States, and Europe. Founded in 2018, Flora Growth has quickly grown through acquisitions and partnerships, becoming a prominent player in the global cannabis market.

Core Business Areas: Flora Growth operates across multiple segments:

  • Cultivation & Production: Owning and operating cannabis farms in Colombia and the United States.
  • Brands & Products: Developing and marketing a diverse portfolio of cannabis-based products, including dried flower, pre-rolls, concentrates, edibles, and topicals.
  • Distribution & Retail: Establishing distribution channels and retail stores in key markets, including the US and Colombia.

Leadership & Structure: Flora Growth has a seasoned leadership team with expertise across the cannabis industry.

  • Luis Merchan - Executive Chairman & Founder: Extensive experience in building successful businesses in various industries.
  • Ramsey Ben-Ami - Chief Executive Officer: Background in finance and investments with a focus on the cannabis sector.
  • Cam Battley - President: Over two decades of experience in cannabis cultivation, processing, and retail operations.

Top Products and Market Share:

Products:

  • House of Brands Portfolio: A range of cannabis brands targeting various consumer segments.
  • Kasa Wholefoods & Beverages: Cannabis-infused food and beverage products.
  • JustCBD & Hempstead: CBD-focused brands offering various product categories.
  • Lyfted Farms & Stardawg: High-quality cannabis flower brands.

Market Share:

  • Limited Data: Flora Growth's market share data is limited due to its recent growth and focus on emerging markets.
  • Estimated Share: Based on available data and analyst estimates, Flora Growth holds a small market share in the global and US cannabis markets, with potential for future expansion.

Total Addressable Market (TAM):

Global Cannabis Market:

  • Current Size: Estimated to be around $30 billion in 2023.
  • Projected Growth: Expected to reach over $100 billion by 2030, with significant growth potential in emerging markets like the US and Canada.

US Cannabis Market:

  • Current Size: Approximately $25 billion in 2023.
  • Projected Growth: Estimated to reach $45 billion by 2025, driven by increasing legalization across states.

Financial Performance:

Financial Statements:

  • Revenue: Growing steadily, reaching $26.3 million in Q2 2023.
  • Net Income: Negative, reflecting the company's investment phase.
  • Profit Margins: Still under development, expected to improve as scale increases.
  • EPS: Currently negative due to profitability challenges.

Y-o-Y Comparison: Revenue has increased significantly year-over-year, reflecting successful acquisitions and market penetration efforts.

Cash Flow & Balance Sheet: Cash flow is currently negative due to investments in growth initiatives. The company is working to improve cash flow and balance sheet health through operational efficiencies and revenue growth.

Dividends and Shareholder Returns:

Dividend History: No dividend history as the company is focused on reinvesting profits for growth.

Shareholder Returns: Total shareholder returns have fluctuated significantly, largely due to market volatility surrounding cannabis stocks.

Growth Trajectory:

Historical Growth: Revenue has increased significantly over the past few years through strategic acquisitions and expansion.

Future Growth: Flora Growth projects continued revenue and market share growth, driven by:

  • Increasing product portfolio and brand development.
  • Expanding distribution network.
  • Entering new markets and states.
  • Optimizing operational efficiency.

Market Dynamics:

Industry Trends: The global cannabis industry is experiencing rapid growth and increasing acceptance, driven by legalization efforts and evolving consumer preferences.

Demand & Supply: Demand is outpacing supply in many markets, creating opportunities for companies with strong production and distribution capabilities.

Technological Advancements: Technological innovations in cultivation, extraction, and product development are driving industry efficiency and product quality.

Flora Growth's Positioning: Flora Growth is well-positioned in this evolving market due to its:

  • Strong production capacity.
  • Diversified product portfolio.
  • Experienced leadership team.
  • Focus on innovation and technology.
  • Established presence in key markets.

Competition:

Key Competitors:

  • Curaleaf Holdings (CURLF)
  • Trulieve Cannabis (TCNNF)
  • Green Thumb Industries (GTI)
  • Tilray (TLRY)
  • Canopy Growth (CGC)

Market Share Comparison: Flora Growth's market share is currently smaller compared to these major players, but the company has the potential to gain significant ground through continued expansion and market penetration efforts.

Competitive Advantages: Flora Growth's competitive advantages include its:

  • Low-cost cultivation in Colombia.
  • Branded product portfolio.
  • Experienced management team.
  • Focus on emerging markets with high growth potential.

Potential Challenges & Opportunities:

Challenges:

  • Intense competition in the cannabis industry.
  • Regulatory uncertainty in some markets.
  • Access to capital and financing.
  • Maintaining profitability and cash flow.

Opportunities:

  • Expanding into new markets and states with legalization potential.
  • Product innovation and development of differentiated offerings.
  • Strategic partnerships and acquisitions.

Recent Acquisitions:

  • HBI International (2021): Acquired for approximately $200 million, providing Flora Growth with a significant greenhouse and production facility in Colombia.
  • JustCBD (2021): Acquired for $25 million, adding a well-established CBD brand to Flora's portfolio.
  • Hempstead (2021): Acquired for $2 million, further strengthening Flora Growth's presence in the CBD market.
  • Vessel Brand (2023): Acquired for $25 million, expanding the company's presence in the premium vaporizer market.

AI-Based Fundamental Rating:

Rating: 6.5/10

Justification:

  • Strong growth potential driven by market trends and expansion plans.
  • Diversified product portfolio and experienced leadership.
  • Potential challenges with profitability, competition, and regulatory uncertainties.
  • Investment in growth may lead to dilution for existing shareholders.

Disclaimer: This information is for informational purposes only and should not be considered as investment advice. Investing in the stock market comes with inherent risks, and you should always conduct your own research before making any investment decisions.

** Sources:**

About Flora Growth Corp

Exchange NASDAQ
Headquaters Fort Lauderdale, FL, United States
IPO Launch date 2021-05-11
CEO & Director Mr. Clifford A. Starke
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 97
Full time employees 97

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​